New study suggests why mice with cystic fibrosis mutations can stave off bacterial infections in ... The genetic defect that causes cystic fibrosis cripples these defenses. CFTR proteins normally ...
Liu explained that they attempted to edit mutated CFTR as well but with limited ... treatments for those with rarer CF mutations too,” said Lucy Allen, a lung biologist and research director at Cystic ...
mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, located on chromosome 7, were found to be ...
The Massachusetts-based biotech plans to use the funds to push its candidates into mid-stage clinical trials in a space ...
Sionna Therapeutics is eyeing a $156 million IPO as the cystic-fibrosis-focused biotech looks to take its lead candidate into ...
2 Once developed and tested, this approach could allow clinicians to treat every patient with cystic fibrosis ... s cells must produce the CFTR protein for the existing therapies to work, which leaves ...
By the time Enid Katz was two years old, she had already suffered through several bouts of bronchitis and was always hungry, ...
ReCode Therapeutics is set to secure up to $15m in additional funding from the Cystic Fibrosis Foundation ... stemming from mutations in the CFTR gene. The company’s lead programmes, RCT2100 ...
Patients aged 6 to 11 years with cystic fibrosis receiving 24-week once-daily vanzacaftor/tezacaftor/deutivacaftor generally ...
An international study has identified two types of these so-called dysbioses in cystic fibrosis. They display ... Landmark Study Involving Babies in Ireland Supports Use of Cystic Fibrosis Drug in ...
Vertex Announces US FDA Approval of ALYFTREK™, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis ... including 31 additional mutations not responsive to other ...
The commitment of organizations like the Cystic Fibrosis Foundation to global research funding and access initiatives has further propelled market growth. Additionally, major pharmaceutical companies, ...